Boehringer Ingelheim headquarters move bringing 75 jobs to Duluth

Gov. Brian Kemp and Partnership Gwinnett officials announced this past week that the moving of Boehringer Ingelheim Vetmedica’s North America and U.S. headquarters to Duluth will bring 75 jobs to the area. (Special Photo) Boehringer Ingelheim. (PRNewsFoto/Boehringer Ingelheim Vetmedica, Inc.)

The impact Boehringer Ingelheim’s headquarters move to Duluth will have on the local job market became clear this past week.

The animal health company is expected to bring 225 jobs to Georgia, including 75 at its headquarters in Duluth, according to an announcement from Partnership Gwinnett and Gov. Brian Kemp. The company announced plans to move its North American headquarters from Missouri to Duluth in November, but the number of jobs that was expected to generate was not released until this week’s announcement.

“We’re excited to welcome Boehringer Ingelheim Animal Health USA Inc. to the Peach State,” Kemp said in a statement. “As a family-owned business, they will join a first-class corporate family here in Georgia. I look forward to working with them to strengthen our university system and existing industries in agribusiness, health technology, and science.”

In addition to the jobs in Duluth, Boehringer Ingelheim is expected to create 50 new jobs at a manufacturing facility in Gainesville and 100 jobs at a research and development facility in Athens.

The company makes vaccines and pharmaceuticals for animals.

“For nearly 40 years, the company and its predecessors have helped make the state of Georgia a key player in animal health — from its beginning producing rabies vaccines in Athens, to multiple facilities today, that are playing an instrumental role in advancing animal health and well-being,” Boehringer Ingelheim Animal Health USA Inc. President Everett Hoekstra said in a statement.

“Our investments will expand our capabilities and presence in Georgia, and drive future growth and innovation to help prevent disease in livestock and pets.”

Local officials praised the jobs announcement, using it to highlight attributes they feel Gwinnett County and the Gwinnett Place Community Improvement District — where the headquarters will be located — have that are attractive to businesses.

“This announcement is yet another excellent example of how Gwinnett’s robust business climate and diverse community continue to draw companies to locate and expand here,” Partnership Gwinnett Chief Economic Development Officer Nick Masino said.

“Industry giants, like Boehringer Ingelheim, recognize Gwinnett County as a prime location to better reach their target markets and grow their business.”

Gwinnett Place CID Executive Director Joe Allen said, “Boehringer Ingelheim’s decision to invest in the Gwinnett Place CID speaks to the strength of our community and the economic vitality of this area.

“With access to a skilled workforce and significant infrastructure, companies like Boehringer Ingelheim are able to successfully grow and expand their business with confidence.”

Support Local Journalism

Now, more than ever, the world needs trustworthy reporting—but good journalism isn’t free. Please support us by subscribing or making a contribution today.

I'm a Crawford Long baby who grew up in Marietta and eventually wandered to the University of Southern Mississippi for college. Earned a BA in journalism (double minor in political science and history). Previously worked in Florida and Clayton County.

(0) comments

Welcome to the discussion.

Please log in, or sign up for a new, free account to read or post comments.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.